NASDAQ · Biotechnology

Evogene Ltd. (EVGN) Stock

$0.38 -4.09% NASDAQ: EVGN Healthcare

Valuation

MetricValue
Price$0.38
Market Cap$3.29M
P/E Ratio-0.44
P/B Ratio-1.52
P/S Ratio2.70
EPS (TTM)$-1.08
52-Week High$1.50
52-Week Low$0.35
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE761.97%
ROA-67.68%
ROCE-128.22%
Gross Margin-350.00%
Operating Margin-350.00%
Net Margin-696.26%
Debt/Equity-0.63
Current Ratio5.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$2.0M$3.0M$6.0M$4.0M
Operating Profit$-31.0M$-27.0M$-22.0M$-19.0M$-14.0M
Net Profit$-28.0M$-27.0M$-24.0M$-16.0M$-8.0M
EPS$-0.68$-6.46$-5.23$-2.89$-1.08
Op Margin-3328.3%-1608.4%-745.5%-337.2%-364.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$76.0M$56.0M$51.0M$40.0M$20.0M
Total Liabilities$13.0M$21.0M$22.0M$25.0M$8.0M
Cash$32.0M$29.0M$21.0M$15.0M$13.0M
Borrowings$3.0M$12.0M$12.0M$13.0M$2.0M

Latest News

AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities PR Newswire · Jul 15, 2026 Evogene and Tel Aviv University launch drug discovery initiative Pharmaceutical Technology · Jul 9, 2026 Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery PR Newswire · Jul 8, 2026 Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization PR Newswire · Jun 24, 2026 Evogene to Present Its Pharma Division Achievements at the BIO International Convention PR Newswire · Jun 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-25.0M$-24.0M$-22.0M$-20.0M$-14.0M
Investing Cash Flow$-21.0M$12.0M$-5.0M$9.0M$18.0M
Financing Cash Flow$1.0M$0$11.0M$5.0M$-10.0M
Net Cash Flow$-14.0M$-3.0M$-8.0M$-5.0M$-2.0M
Free Cash Flow$-26.0M$-25.0M$-22.0M$-20.0M$-14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.31
FCF Yield-337.16%
Quick Ratio3.54
Interest Coverage-2.73
Return 1Y-54.01%
Return 3Y-95.86%
Return 5Y-98.07%

Ownership

Insiders Held0.96%
Institutions Held6.25%
Institutions Float Held6.31%
Institutional HolderSharesReport Date
SilverArc Capital Management, LLC308,5502024-03-31
Morgan Stanley28,4042024-03-31
BNP Paribas Financial Markets9,1402024-03-31
LPL Financial LLC6,6842024-03-31
JP Morgan Chase & Company3,9432024-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AEONAEON Biopharma, Inc. $0.28 -10.97% -0.08 $12.19M 0.00%
BOLTBolt Biotherapeutics, Inc. $4.11 +12.60% -0.22 $7.90M 0.00%
CINGCingulate Inc. $4.89 +0.20% -0.95 $65.86M 0.00%
CLRBCellectar Biosciences, Inc. $1.45 +3.57% -0.39 $11.59M 0.00%
COCPCocrystal Pharma, Inc. $1.07 +0.00% -1.49 $14.75M 0.00%

About Evogene Ltd.

Evogene Ltd. is led by CEO Ofer Haviv, employs 117 people, headquartered in IL, publicly traded since 2010.

Evogene Ltd. (EVGN) stock trades at $0.38 with a market capitalization of $3.29M. The stock is valued at a price-to-earnings (P/E) ratio of -0.44, price-to-book of -1.52, price-to-sales of 2.70. Over the past 52 weeks the stock has ranged between $0.35 and $1.50, and currently trades 74.7% below its 52-week high.

On profitability, Evogene Ltd. generates a return on equity (ROE) of 761.97% — well above the market average, a sign of a high-quality business, return on capital employed of -128.22%, an operating margin of -350.00%, a net profit margin of -696.26%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides